Navigation Links
Aedes Agypti Mosquitos Immune System Revealed

The immune system of this mosquito is of great importance as scientists believe it plays a key role in controlling the transmission of viruses that cause yellow and dengue fevers diseases that infect over 50 million people worldwide every year.The genes that make up the immune system of the Aedes aegypti mosquito which transmits deadly viral diseases to humans have been identified.

This study is the first of its kind on the newly-sequenced genome of the Aedes aegypti mosquito, which is also published in this weeks Science. The researchers identified over 350 genes which are involved in the Aedes mosquitos immune system, and discovered that they evolve much faster than the rest of the genes in the genome.

Identifying which of these key genes are implicated in the transmission of viral diseases is an area of future research that could lead to new ways of combating these diseases. One possibility would be to affect the activity of the genes and therefore help the mosquitoes fight off the viruses more effectively, preventing transmission to humans.

Imperial College scientists participating in this study established previously that other mosquitoes do have a robust immune system that can either allow or block transmission of malaria parasites. Further research will be needed to ascertain whether some of the newly discovered genes in Aedes may provide a similar defence mechanism that can fight the disease viruses.

Dr George Christophides of Imperials Division of Cell and Molecular Biology, senior author on the paper explains: Our study has revealed the genetic landscape made by parts of this mosquitos newly-sequenced genome which are involved with immunity.

By working to understand as much as possible about these genes, and the way they interact with specific pathogens, we hope to gain a more complete understanding of the mechanisms by which a pathogen either survives inside the insect body, or is killed by the ins
'"/>




Page: 1 2

Related medicine news :

1. Immune cells halt round in space
2. Immune function could benefit from exercise
3. Reviving the Immune System
4. Wrestling found To Be Good for the Immune System
5. Immune Boost With LHRH To Help Cancer And Transplant Patients
6. Researchers Find Out The Cause Of Immune Attacks Behind Hearing Loss
7. Block Immune System Chemical For Treating Asthma
8. Immune Response Of Human Beings Can Be Re-energized
9. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
10. Antidepressant drugs interacts with Immune cells
11. Specific Immune Mechanism against DNA viruses
Post Your Comments:
(Date:9/5/2008)... Saturday, September 6, PARI,Respiratory Equipment...,s,Family as part of their "Breathe Easier" series...company that provides patients, such as COPD,suffe...at deliver needed,medications directly to the lung...affected by respiratory,diseases and those who car...
(Date:9/5/2008)...ht or obese at age 45 , , FRIDAY, Sept. ...adults will develop osteoarthritis of the knee by ...in middle age, a new study says. , A person,s ...his or her body-mass index (BMI) rose, according t...study. People who were of normal weight at age 18 ...
(Date:9/5/2008)...are enhanced by taking into account risk factors b...ding to research teams led by epidemiologists at T...r in two complementary papers appearing in the Sep...In the first study to focus on African-Americans, ...d exposure to certain risks. Based upon these find...
(Date:9/4/2008)...care Advantage (MA) plans will be paid an average ... what the same enrollee would have cost in the tra...ng to a new report from The Commonwealth Fund. Ev...by the Medicare Improvements for Patients and Prov...t beginning in 2010 had been fully in place in 20...
Breaking Medicine News(10 mins):Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2
...ed alert due to Chikungunya outbreak in the city a...elfare.// In spite of the efforts of the Health ...d the disease at source, the mosquitoes continue t...eues of patient’s suffering from the disease. C...
...as a hazard of aging, but researchers actually do ...consequence of aging// or not. Researchers at the ...pps Research Institute have now conducted a study ...al for diseases like Alzheimer's. Harmful beta am...
...g users who completed the treatment for drug addic... number of people enrolling// for the treatment in...out of treatment if they had been coerced into it ...ntered by other routes. This was reported by a Bri...
...e in the American Society, not only among women bu...men under pressure to have a good physique may suf...s, and an unhealthy preoccupation with weightlifti...muscular men in the media and feel their own bodie...
Other Medicine News:Health News:Chikungunya Outbreak 2Health News:Aging Critical For Alzheimer's Disease 2Health News:Aging Critical For Alzheimer's Disease 3Health News:Men Take to Unhealthy Practices to be More Muscular 2
(Date:9/4/2008)... on Schedule with Two Abstracts Accepted for P...vember 2008, BRIDGEWATER, N.J., Sept. 4 /PRNewswi... pharmaceutical company focused on the treatment o...unced the appointment of,Peter L. Garrambone, Jr. ...mbone,s career includes more than 50 pharmaceutica...
(Date:9/3/2008).../- Simcere,Pharmaceutical G...plier of,branded generic pharmaceuticals and manuf...t Endu (also known as Endostar) in China,announce...udy., At the request of the SFDA, Simcere initiat...he safety and therapeutic efficacy of Endu, a modi...
(Date:9/3/2008)...onal Vascular Disease Awareness Month, CHARLOTTES...maceuticals,LLC, a clinical-stage drug-development...nt of unmet medical needs, announced today that it...ical trial of its lead drug,candidate trans sodium...881,on the clinicaltrials.gov Website, is investig...
(Date:9/3/2008)...Multaq(R) (dronedarone) decreased the risk of,stro...trial flutter already adequately trea... Sept. 3 /- The results of ...udy were presented today at,the clinical trial upd...congress 2008, in Munich, Germany. Previous result...
Breaking Medicine Technology:Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 1Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 2Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 3Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 4Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 5Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 6Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 7Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives 7826 8Submission of Marketing Authorisation Application for Dapoxetine in Europe 7823 1Submission of Marketing Authorisation Application for Dapoxetine in Europe 7823 2Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 1Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 2Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 3Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 4Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 5Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 6Katie Lee Joel to Conduct Free Hands On Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2103 7Tutogen Medical Inc to Report Fourth Quarter and Fiscal Year 2007 Financial Results 2100 1Tutogen Medical Inc to Report Fourth Quarter and Fiscal Year 2007 Financial Results 2100 2
...007 – On 23 July SYGNIS Pharma,AG will prese...,AX200 (AXIS-study)., AX200, a compound for the tr...date in SYGNIS’ product pipeline. The,primar...ity of,AX200 in acute stroke patients. The results...tion for the further clinical,development of AX200...
...swire-FirstCall/ -- On Wednesday,July 11, 2007, a...entral European Time members of Cell Therapeutics,...ce call to discuss today,s,announcement of the int...ring CHOP-R to CPOP-R, in which pixantrone is subs...st-line treatment of patients,with aggressive non-...
Other Medicine Technology:Sygnis Pharma AG announces date for presentation of clinical,results 2Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: